ukmla MCQ (SBA): Schizophrenia

Instant feedback + full explanation. One question, done properly.

MediumPharmacology & PrescribingSchizophreniaukmlamrcgp aktmrcp part 1prescribing safety assessment

A patient with schizophrenia on olanzapine develops significant weight gain and metabolic syndrome. According to NICE, which antipsychotic has a lower metabolic risk and may be considered?

Educational content. Not a substitute for clinical judgement or local policy.

ukmla MCQ: Schizophrenia — Answer & Explanation | iatroX